<p>Spyridon Tsakas of Eulysis UK Limited in the United Kingdom will test an innovative single vial system (SVS) technology that allows for easier transport, reconstitution, and storage of vaccines with lyophilized components. Data gathered on its packaging, transportability and in situ lyophilization potential will help optimize the technology for safe vaccine delivery to the developing world.</p>


Spyridon Tsakas of Eulysis UK Limited in the United Kingdom will test an innovative single vial system (SVS) technology that allows for easier transport, reconstitution, and storage of vaccines with lyophilized components. Data gathered on its packaging, transportability and in situ lyophilization potential will help optimize the technology for safe vaccine delivery to the developing world.